scholarly article | Q13442814 |
P50 | author | Ana María Cuervo | Q19766132 |
Claire C Bastie | Q37374193 | ||
P2093 | author name string | Hiroshi Koga | |
Jeffrey E Pessin | |||
Yichen Wang | |||
Eijiro Yamada | |||
P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 |
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids | Q24306330 | ||
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1 | Q24634669 | ||
Fyn: a novel molecular target in cancer | Q28273098 | ||
The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond | Q28278349 | ||
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 | Q28506431 | ||
Methods in mammalian autophagy research | Q29547276 | ||
Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells | Q29614482 | ||
FoxO3 controls autophagy in skeletal muscle in vivo | Q29614483 | ||
The role of the Atg1/ULK1 complex in autophagy regulation | Q29614497 | ||
Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy | Q29615616 | ||
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression | Q29617506 | ||
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 | ||
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn. | Q30157097 | ||
Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle | Q31509381 | ||
Lysosomal proteolysis in skeletal muscle | Q33222353 | ||
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy | Q33589972 | ||
Altered lipid content inhibits autophagic vesicular fusion | Q34017069 | ||
LKB1-dependent signaling pathways | Q34535140 | ||
Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy | Q34891582 | ||
Deptor knockdown enhances mTOR Activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy | Q35286938 | ||
AMPK, the metabolic syndrome and cancer | Q36024356 | ||
Signaling pathways in skeletal muscle remodeling | Q36498310 | ||
AMP-activated protein kinase signaling in metabolic regulation | Q36528537 | ||
mTOR pathway as a target in tissue hypertrophy. | Q36591617 | ||
Interaction between the AMP-activated protein kinase and mTOR signaling pathways | Q36649629 | ||
Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells | Q36656749 | ||
The regulation and function of Class III PI3Ks: novel roles for Vps34. | Q37063618 | ||
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease | Q37089630 | ||
mTOR couples cellular nutrient sensing to organismal metabolic homeostasis | Q37097444 | ||
AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism | Q37276696 | ||
AMPK: a metabolic gauge regulating whole-body energy homeostasis | Q37314854 | ||
LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism | Q37543834 | ||
Autophagy in skeletal muscle | Q37687551 | ||
The AMPK-FoxO3A axis as a target for cancer treatment | Q37700098 | ||
Regulation of membrane biogenesis in autophagy via PI3P dynamics | Q37733856 | ||
Autophagy in the cellular energetic balance | Q37870537 | ||
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor | Q40091020 | ||
Coordinated maintenance of muscle cell size control by AMP-activated protein kinase | Q42164316 | ||
Monitoring autophagy in muscle diseases | Q42449474 | ||
Fasting-related autophagic response in slow- and fast-twitch skeletal muscle | Q43149447 | ||
Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy | Q46112113 | ||
AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. | Q48302574 | ||
Autophagy is required to maintain muscle mass. | Q51411361 | ||
Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. | Q51471758 | ||
Atg14 and UVRAG: mutually exclusive subunits of mammalian Beclin 1-PI3K complexes. | Q51815815 | ||
Autophagy is defective in collagen VI muscular dystrophies and its reactivation rescues myofiber degeneration | Q57639972 | ||
Expression of a novel form of the fyn proto-oncogene in hematopoietic cells | Q69154785 | ||
P433 | issue | 5 | |
P304 | page(s) | 557-569 | |
P577 | publication date | 2012-05-03 | |
P1433 | published in | Cell Reports | Q5058165 |
P1476 | title | Mouse skeletal muscle fiber-type-specific macroautophagy and muscle wasting are regulated by a Fyn/STAT3/Vps34 signaling pathway | |
P478 | volume | 1 |
Q37610585 | "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders |
Q57498216 | A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics |
Q42443337 | Autophagic flux and oxidative capacity of skeletal muscles during acute starvation |
Q38942187 | Autophagy in Pulmonary Diseases |
Q54239903 | Autophagy is altered in skeletal and cardiac muscle of spontaneously hypertensive rats. |
Q30410425 | Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance |
Q37429067 | Autophagy regulation by nutrient signaling |
Q64088609 | Constant-Moderate and High-Intensity Interval Training Have Differential Benefits on Insulin Sensitive Tissues in High-Fat Fed Mice |
Q49718088 | Distinct signal transductions in fast- and slow- twitch muscles upon denervation |
Q42907623 | Dysfunctional transcripts are formed by alternative polyadenylation in OPMD. |
Q48118265 | FoxO1-AMPK-ULK1 Regulates Ethanol-Induced Autophagy in Muscle by Enhanced ATG14 Association with the BECN1-PIK3C3 Complex |
Q36139815 | Fyn Activation of mTORC1 Stimulates the IRE1α-JNK Pathway, Leading to Cell Death |
Q36795964 | Fyn deficiency promotes a preferential increase in subcutaneous adipose tissue mass and decreased visceral adipose tissue inflammation. |
Q39392366 | Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy |
Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
Q59790432 | HMGB1/autophagy pathway mediates the atrophic effect of TGF-β1 in denervated skeletal muscle |
Q37071161 | High-fat feeding does not induce an autophagic or apoptotic phenotype in female rat skeletal muscle |
Q64951184 | Honokiol Protects against Anti-β1-Adrenergic Receptor Autoantibody-Induced Myocardial Dysfunction via Activation of Autophagy. |
Q48066542 | IGF-1-Involved Negative Feedback of NR2B NMDA Subunits Protects Cultured Hippocampal Neurons Against NMDA-Induced Excitotoxicity |
Q36262523 | IL-6 Inhibits Starvation-induced Autophagy via the STAT3/Bcl-2 Signaling Pathway |
Q26866208 | Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? |
Q51231318 | Isoflavin-β modifies muscle oxidative stress and prevents a thyrotoxicosis-induced loss of muscle mass in rats. |
Q64376930 | Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle |
Q41579787 | Long-term PGC1β overexpression leads to apoptosis, autophagy and muscle wasting. |
Q60679786 | Macrophage polarization contributes to local inflammation and structural change in the multifidus muscle after intervertebral disc injury |
Q38089508 | Mechanisms for fiber-type specificity of skeletal muscle atrophy |
Q40619076 | Muscle-specificity of age-related changes in markers of autophagy and sphingolipid metabolism |
Q37344096 | Nutrient ingestion increased mTOR signaling, but not hVps34 activity in human skeletal muscle after sprint exercise |
Q91756147 | Opportunities and challenges of co-targeting epidermal growth factor receptor and autophagy signaling in non-small cell lung cancer |
Q60054004 | Oxidative muscles have better mitochondrial homeostasis than glycolytic muscles throughout life and maintain mitochondrial function during aging |
Q36907076 | Pyrvinium targets autophagy addiction to promote cancer cell death |
Q38835708 | Redox regulation of autophagy in skeletal muscle |
Q64120943 | Regulation of Skeletal Muscle DRP-1 and FIS-1 Protein Expression by IL-6 Signaling |
Q45737026 | SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes |
Q36900212 | Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases |
Q26866957 | Skeletal muscle autophagy: a new metabolic regulator |
Q90540850 | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution |
Q38684406 | The novel role of pyrvinium in cancer therapy. |
Q28084959 | The role of STAT3 in autophagy |
Search more.